Biologic Videos

  1. Cytovance Biologics Capabilities Update March 2026: Large Molecule 3/17/2026

    How a seasoned development and manufacturing team blends technical depth, reliability, and flexible support to advance large‑molecule programs amid shifting timelines, costs, and regulatory demands.

  2. What Matters More In DNA-Encoded Libraries? 3/16/2026

    DELs can screen billions of compounds, but library quality determines meaningful results. See how thoughtful design shapes early decisions that influence which drug candidates move forward.

  3. In Vitro Transcription For mRNA Production 3/13/2026

    Efficient mRNA production relies on optimized IVT conditions, where NTPs, enzymes, and critical additives work together. Explore how the right components strengthen mRNA synthesis at every step.

  4. Trends In Mid-Size Scale Up Strategies 3/13/2026

    A development leader highlights supply‑chain resilience, cost‑efficient large‑scale manufacturing, proven tech‑transfer success, and long‑term commitment to supporting clients through reliable scale‑up and global production strategies.

  5. Sustainable Manufacturing Through Automation, Flow Chemistry, And Biocataysis 3/12/2026

     Learn how modeling, high-throughput tools, and advanced analytics enable safer, more efficient routes and support scalable solutions for complex chemical and enzymatic processes.

  6. My Journey at Asymchem 3/12/2026

    From flow chemistry to biocatalysis and synthetic biology, he shares how these platform technologies are transforming customer projects — and extending impact to the food, agriculture, and energy industries.

  7. Quick View Of Asymchem's New OEB5 Facility 3/12/2026

    Explore Asymchem’s OEB5 high-potency facility — a 6,000 m², fully enclosed site integrating R&D, manufacturing, and analytics under CPT ≤1 ng/m³ containment.

  8. Asymchem's State-Of-The-Art HTE Platform 3/12/2026

    Steve Fussell, Senior Manager – High-Throughput Experimentation (HTE) at Asymchem, introduces our state-of-the-art HTE laboratory, where automation, robotics, and data-driven insights transform process R&D.

  9. ROIS Capabilities Update March 2026: Fill/Finish 3/10/2026

    End‑to‑end aseptic fill‑finish services across multiple injectable formats, supporting biologics and small molecules with advanced capabilities and available large‑scale capacity.

  10. medac CDMO Capabilities Update March 2026: Fill/Finish 3/10/2026

    A purpose‑built sterile manufacturing model enables reliable scale‑up, operational agility, and resilient global supply for complex injectables, supported by strong infrastructure and process design.